Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
EnteroMedics said it named Dan Gladney, the former chief executive who led Lanx to an acquisition by Biomet, to be its new CEO effective Nov. 16.
St. Paul, Minn.-based EnteroMedics said chairman, president & CEO Mark Knudson will become executive chairman when Gladney takes over the corner office until Jan. 1, 2016, when he will become non-executive chairman. Read more
Danaher subsidiary Nobel Biocare notched a mixed win in the initial determination from the U.S. International Trade Commission in its patent war with a Straumann subsidiary and a Brazilian manufacturer over dental implant technology.
Nobel Biocare filed a complaint in October 2014 with the ITC, asking for an investigation of the importation and sale of the Neodent DriveCM dental implant, made by Brazilian subcontractor JJGC Indústria e Comércio de Materiais Dentários and sold by Straumann subsidiary Instradent. Neodent stopped using the allegedly infringing design after the ITC launched its investigation. Read more
Titan Medical said it agreed to a private placement deal with a subsidiary of Chinese medical device distributor Ningbo Long Hengtai International Trade Co. that could wind up being worth more than $24 million.
Toronto-based Titan Medical said the deal with Canada-based Longtai Medical involves an initial, $4 million private placement priced at $1.23 per share, expected to close Nov. 15. Read more